title: Management of patients with atrial fibrillation. A Statement for Healthcare Professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association.
authors.affiliation: American Heart Association, Dallas, TX 75231-4596, USA.
authors.forename: E N
authors.initials: EN
authors.lastname: Prystowsky
authors.forename: D W
authors.initials: DW
authors.lastname: Benson
authors.forename: V
authors.initials: V
authors.lastname: Fuster
authors.forename: R G
authors.initials: RG
authors.lastname: Hart
authors.forename: G N
authors.initials: GN
authors.lastname: Kay
authors.forename: R J
authors.initials: RJ
authors.lastname: Myerburg
authors.forename: G V
authors.initials: GV
authors.lastname: Naccarelli
authors.forename: D G
authors.initials: DG
authors.lastname: Wyse
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D001281:Atrial Fibrillation / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D002561:Cerebrovascular Disorders / Q000517:prevention & control; D006439:Hemodynamics; D006801:Humans; D013923:Thromboembolism / Q000517:prevention & control
chemical_list: D000889:Anti-Arrhythmia Agents